Thomson Medical – Limited Impact from Proposed Distribution of RE Business. Still Looks Expensive.

Thomson Medical Group: Medicated by Leverage

Jubilant Pharma: Good Drugs, Fully-Valued Bonds

APAC IPOs & Placements

Zhen Zhou, Toh

Smartkarma

Smartkarma unites the fragmented investment industry, connecting institutional investors, independent research providers, and corporates within a single network.

Research Reinvented

Event-Driven

Thomson Medical Group Limited / Event-Driven

<p><a href="https://www.smartkarma.com/entities/8495" target="_blank" data-smartkarma-citation="entities:8495:1">Rowsley Ltd (ROWS SP)</a> announced that earlier in July that it will be buying Sasteria, the company that holds Thomson Medical. On 18th December, the company released a corporate presentation as the company entered into a sale and purchase agreement (S&amp;P agreement).</p><p>Post announcement, Rowsley's share price rallied about 20% from the previous close, but, we think that the market has been showing a tad too much of irrational exuberance.</p><figure class="editor-figure mceNonEditable"><img src="https://static-prod.smartkarma.com/images/media/000/040/773/original/One-Year-Price-Chart-of-Rowsley-SGD-Last-Price-Volume-000-_chartbuilder.png?1513667338" class="editor-image img-responsive" data-smartkarma-image-id="40773"></figure><h2>Details of the acquisition<br><br>
</h2><ul><li>Rowsley will be buying Sasteria for…</li></ul>

Rowsley Ltd (ROWS SP) announced that earlier in July that it will be buying Sasteria, the company that holds Thomson Medical. On 18th December, the company released a corporate presentation as the company entered into a sale and purchase agreement (S&amp;P agreement).Post announcement, Rowsley's share price rallied about 20% from the previous close, but, we think that the market has been showing a tad too much of irrational exuberance.Details of the acquisition  
Rowsley will be buying Sasteria for…

Signs of Irrational Exuberance as Rowsley Transforms into Thomson Medical